nVNS, CBD, and SoC for Persistent Post-Traumatic Headache

Part of paid clinical trials in Scottsdale, Arizona.

Sponsor
American Society of Pain and Neuroscience, Inc.
Study ID
NCT07624279
Phase
PHASE2
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Persistent Post Traumatic Headache

Eligibility Criteria

Sex
ALL
Age
18 Years - 75 Years
Healthy Volunteers
Not accepted

Interventions

  • Non-Invasive Vagus Nerve Stimulation — DEVICE
    Two treatments to the cervical vagus nerve twice daily
  • Cannabidiol — DRUG
    Dosage titrated as per schedule
  • Standard of Care — DRUG
    Oral pharmacotherapy as selected by site investigator and participant

Study Details

Do cannabidiol (CBD) or vagus nerve stimulation reduce the frequency of persistent post-traumatic headache more than traditional oral headache medications?

Key Dates

Start date
Jun 1, 2026
Status verified
May 2026
Primary completion
Jul 31, 2027
Completion
Jul 1, 2028

Study Design

Enrollment
80 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Non-Invasive Vagus Nerve Stimulation
  • Experimental: Cannabidiol
  • Experimental: Standard of Care

Primary Outcome Measure

Moderate-severe headache days [ Time Frame: Weeks 9-12 ]

Central Contacts

Locations (8)

FacilityCityStateZIPSite coordinators
Mayo ClinicScottsdaleArizona85054
Natalie Strand, MD
Natalie Strand, MD (PRINCIPAL_INVESTIGATOR)
Kerlan-Jobe Orthopaedic InstituteLos AngelesCalifornia90045
Vernon Williams, MD
Vernon Williams, MD (PRINCIPAL_INVESTIGATOR)
International Spine, Pain & Performance CenterWashington D.C.District of Columbia20006
Mary Meg Valentine, BS
202-849-8333
Mehul Desai, MD (PRINCIPAL_INVESTIGATOR)
Florida Spine & Pain SpecialistsTampaFlorida33614
Nomen Azeem, MD
Nomen Azeem, MD (PRINCIPAL_INVESTIGATOR)
University of Kansas Medical CenterKansas CityKansas66160
Dawood Sayed, MD
Dawood Sayed, MD (PRINCIPAL_INVESTIGATOR)
Premier Pain CenterShrewsburyNew Jersey07702
Katie Gee
732-380-0200
Sean Li, MD (PRINCIPAL_INVESTIGATOR)
University Hospitals Cleveland Medical CenterClevelandOhio44106
Melinda Lawrence, MD
Melinda Lawrence, MD (PRINCIPAL_INVESTIGATOR)
Allegheny General HospitalPittsburghPennsylvania15212
Boyle Cheng, PhD
Boyle Cheng, PhD (PRINCIPAL_INVESTIGATOR)
Patrick DeMeo, MD (PRINCIPAL_INVESTIGATOR)
Praveer Vyas, PhD (SUB_INVESTIGATOR)

Find similar trials in Scottsdale, AZ